Fig. 2From: Clinical application of gelatin sponge microparticles combined with pirarubicin for hepatic transcatheter arterial chemoembolization in breast cancer liver metastasis treatment: results of a single-center long-term studySurvival curve of BCLM after GSMs-TACE, with an mOS of 22 monthsBack to article page